… the aberrant expression of miRNAs and their targeted genes drives ovarian cancer initiation,
… a strong potential to serve as a therapeutic approach for the treatment of ovarian cancer. …

… recurs in most patients within 3 years following treatment due to the development of
chemoresistance (23). Having shown that miR-214 is involved in cisplatin resistance in …

… of microRNA therapies in treating ovarian cancers. The positively correlated microRNA/…
have been identified in various studies [5–15], regulatory mRNA targets of microRNA have …

… A set of 219 genes was predicted to be targeted by 19 miRNAs (Figure 1; see also Table S1
… Interestingly, we performed a demethylation experiment by treating ovarian cancer cells with …

… Thus, the discovery of validated miRNA targets is of great importance. … of carboplatin–paclitaxel
has been adapted as the standard treatment for women with advanced EOC [98]. …

… in the derivation of prognostic miRNA signatures for ovarian cancer, the model has … miRNAs
shared among all three platforms. This is but a fraction of the predicted number of miRNAs in …

… miRNAs based on their targets to clarify their probable molecular mechanisms during cisplatin
resistance in ovarian tumor … OC cells to DDP-treatment via mTOR targeting [55]. The mTOR…

… of miRNAs in chemoresistance and sensitivity in the regulation of ovarian cancer. … Changing
the paradigm in the treatment of platinum-sensitive recurrent ovarian cancer: from platinum …

… The most commonly employed chemotherapeutic drug for ovarian cancer treatment is cisplatin.
… Current bioinformatics methods for predicting miRNA targets provide large numbers of …

… The optimal management modality for ovarian cancer … of miRNA-200 family members in
ovarian tumors obtained from … based treatment; some miRNAs have been identified as putative …